Atlas Trials

Pancreatic Neuroendocrine Tumors

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pancreatic Neuroendocrine Tumors

RecordFirmDate
A Clinical Risk Score to Stratify High-risk PanNETs (NCT07695532)Fudan University2017-06-01
Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China (NCT02842749)Novartis Pharmaceuticals2016-03-14
Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project (NCT02685553)Universita di Verona2016-02-01
Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria (NCT02841865)Grupo Espanol de Tumores Neuroendocrinos2015-07-24
The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors (NCT02282059)Pfizer2014-12-12
Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms (NCT02125929)Peking Union Medical College Hospital2014-04-01
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma (NCT02110563)Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2014-04-01
Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors (NCT02586844)University Health Network, Toronto2013-10-01
Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) (NCT03053999)M.D. Anderson Cancer Center2012-10-09
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors (NCT01648465)Hellenic Cooperative Oncology Group2012-08-06
Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy (NCT01384617)Wakayama Medical University2011-06-01
Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors (NCT01381822)Threshold Pharmaceuticals2011-06-01
Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors (NCT01121562)Pfizer2010-07-01
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors (NCT00947167)Pamela L. Kunz2009-03-01

Track Pancreatic Neuroendocrine Tumors automatically

Every clearance here is in the API, with alerts when new ones post.